PeptidePedia The community reference

Customs seizure: difference between revisions

Diff·revision 21 → 22·15:14, 2 Aug 2025

Difference between revision 21 and revision 22 of Customs seizure. 6 lines changed; the page grew by 844 bytes.

Revision 21 — 21:44, 18 Jul 2025
FiveOhThreeB (talk)
expand §How a consignment is handled
3,672 bytes ±0
Revision 22 — 15:14, 2 Aug 2025
FiveOhThreeB (talk)
add short description
4,516 bytes +844
33Community discussion frequently treats a high seizure rate as evidence about a supplier. The confound is jurisdiction: a supplier whose customers are concentrated in a strict jurisdiction will show a higher rate than one whose customers are not, at identical practice. Any comparison that does not hold destination constant is uninterpretable.{{r|reports}}33Community discussion frequently treats a high seizure rate as evidence about a supplier. The confound is jurisdiction: a supplier whose customers are concentrated in a strict jurisdiction will show a higher rate than one whose customers are not, at identical practice. Any comparison that does not hold destination constant is uninterpretable.{{r|reports}}
3434
+35== Consequences for the material ==
+36A detained consignment sits somewhere, and where it sits is not temperature-controlled. A parcel held for two weeks in a customs facility has left its [[Cold-chain freight|cold chain]] and, if it was in a passive shipper, has exhausted it.{{r|usp1079}}
+37
+38This is the practically important consequence and it is often overlooked. The material may be released eventually and may look unchanged, but the storage history is broken and any [[Third-party testing|independent result]] obtained afterwards is characterising the parcel's journey as much as the supplier's manufacture. See [[Chain of custody]] and [[Temperature excursion]].
+39
35== References ==40== References ==
36{{reflist}}41{{reflist}}
37<ref name="fda_pip">United States Food and Drug Administration, ''Regulatory Procedures Manual'', chapter 9 (coverage of personal importations).</ref>42<ref name="fda_pip">United States Food and Drug Administration, ''Regulatory Procedures Manual'', chapter 9 (coverage of personal importations).</ref>
38<ref name="wco">World Customs Organization, ''International Convention on the Simplification and Harmonization of Customs Procedures'' (revised Kyoto Convention).</ref>43<ref name="wco">World Customs Organization, ''International Convention on the Simplification and Harmonization of Customs Procedures'' (revised Kyoto Convention).</ref>
+44<ref name="usp1079">United States Pharmacopeia, General Chapter <1079>, ''Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products''.</ref>
39<ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref>45<ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref>
4046